For the quarter ending 2026-03-31, HNGE made $182,307K in revenue. $34,011K in net income. Net profit margin of 18.66%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 182,307 | 147,897* | 154,211 | 139,098 |
| Cost of revenue | 28,074 | 15,618* | 28,012 | 41,335 |
| Gross profit | 154,233 | 132,279* | 126,199 | 97,763 |
| Research and development | 30,338 | -99,687* | 31,921 | 279,962 |
| Sales and marketing | 68,802 | 829* | 63,520 | 147,228 |
| General and administrative | 23,024 | -102,572* | 36,851 | 251,244 |
| Total operating expenses | 122,164 | -201,431* | 132,292 | 678,434 |
| Income from operations | 32,069 | 333,710* | -6,093 | -580,671 |
| Other income, net | 3,873 | 5,385* | 4,455 | 4,694 |
| Net income before income taxes | 35,942 | 339,094* | -1,638 | -575,977 |
| Provision for income taxes | 814 | 1,178* | 206 | -326 |
| Net income | 35,128 | 337,916* | -1,844 | -575,651 |
| Adjustment to reflect deemed contribution from series d and series e redeemable convertible preferred stock extinguishment | 0 | - | 0 | 0 |
| Unrealized gain (loss) on marketable securities, net of taxes | - | -22* | - | - |
| Income allocated to participating securities | 1,117 | - | 0 | - |
| Comprehensive loss | - | 337,894 | - | - |
| Net income attributable to common stockholders | 34,011 | - | -1,844 | -575,651 |
| Basic EPS | 0.43 | 6.191 | -0.02 | -13.1 |
| Diluted EPS | 0.41 | 6.191 | -0.02 | -13.1 |
| Basic Average Shares | 78,619,000 | 54,577,000* | 78,858,000 | 43,931,000 |
| Diluted Average Shares | 82,394,000 | 54,577,000* | 78,858,000 | 43,931,000 |
Hinge Health, Inc. (HNGE)
Hinge Health, Inc. (HNGE)